| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 175 | 193 | 221 | 210 | 204 | 229 | 269 | 215 | 227 | 257 | 286 | 270 | 276 | 302 | 328 | 305 | 315 | 350 | 380 | 342 | 314 | 277 | 445 | 466 | 445 | 621 | 513 | 509 | 498 | 511 | 543 | 500 | 505 | 555 | 619 | 557 | 564 | 623 | 682 | 622 | 628 | 698 | 755 |
| Expenses | 128 | 140 | 196 | 119 | 144 | 162 | 182 | 160 | 170 | 184 | 200 | 206 | 203 | 217 | 231 | 227 | 235 | 240 | 257 | 246 | 244 | 218 | 305 | 314 | 309 | 418 | 357 | 388 | 364 | 385 | 390 | 376 | 375 | 395 | 424 | 398 | 401 | 432 | 458 | 443 | 434 | 478 | 507 |
| EBITDA | 47 | 53 | 25 | 91 | 60 | 67 | 87 | 55 | 57 | 73 | 86 | 64 | 73 | 84 | 98 | 78 | 80 | 110 | 124 | 96 | 69 | 60 | 140 | 152 | 136 | 203 | 156 | 121 | 133 | 126 | 153 | 124 | 130 | 161 | 196 | 159 | 163 | 191 | 224 | 179 | 195 | 220 | 249 |
| Operating Profit % | 25 % | 26 % | 9 % | 37 % | 27 % | 27 % | 31 % | 23 % | 23 % | 26 % | 28 % | 22 % | 24 % | 26 % | 27 % | 22 % | 22 % | 28 % | 30 % | 25 % | 19 % | 18 % | 29 % | 31 % | 28 % | 31 % | 28 % | 22 % | 25 % | 23 % | 27 % | 23 % | 24 % | 27 % | 30 % | 26 % | 27 % | 28 % | 31 % | 26 % | 28 % | 29 % | 31 % |
| Depreciation | 8 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 8 | 7 | 8 | 8 | 11 | 9 | 9 | 10 | 10 | 16 | 18 | 19 | 20 | 18 | 20 | 20 | 20 | 19 | 21 | 31 | 38 | 36 | 39 | 38 | 38 | 35 | 36 | 36 | 37 | 35 | 35 | 36 | 36 | 35 | 41 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 9 | 12 | 9 | 11 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 5 |
| Profit Before Tax | 39 | 47 | 18 | 84 | 53 | 61 | 80 | 47 | 49 | 66 | 78 | 56 | 62 | 75 | 88 | 68 | 69 | 89 | 102 | 73 | 45 | 38 | 117 | 129 | 111 | 179 | 131 | 82 | 84 | 81 | 103 | 77 | 83 | 118 | 152 | 116 | 120 | 150 | 183 | 138 | 153 | 181 | 204 |
| Tax | 10 | 16 | 11 | 23 | 18 | 21 | 27 | 16 | 17 | 22 | 27 | 19 | 22 | 26 | 31 | 22 | 22 | 30 | 21 | 19 | 13 | 10 | 30 | 33 | 26 | 46 | 34 | 23 | 21 | 23 | 30 | 23 | 26 | 34 | 42 | 34 | 34 | 42 | 52 | 40 | -2 | 47 | 51 |
| Net Profit | 29 | 31 | 7 | 61 | 35 | 40 | 53 | 31 | 32 | 44 | 51 | 36 | 40 | 50 | 57 | 46 | 47 | 59 | 81 | 55 | 33 | 28 | 87 | 96 | 85 | 134 | 96 | 58 | 62 | 58 | 72 | 54 | 57 | 84 | 111 | 82 | 86 | 108 | 131 | 98 | 156 | 134 | 152 |
| EPS in ₹ | 5.28 | 5.61 | 0.99 | 7.37 | 4.17 | 4.88 | 6.47 | 3.78 | 3.80 | 5.40 | 6.19 | 4.39 | 4.88 | 6.00 | 6.92 | 5.56 | 5.72 | 7.14 | 9.77 | 6.56 | 3.94 | 3.45 | 10.34 | 11.44 | 10.10 | 15.87 | 11.49 | 6.93 | 7.41 | 6.97 | 8.64 | 6.37 | 6.84 | 9.95 | 13.16 | 9.77 | 10.13 | 12.79 | 15.52 | 11.60 | 18.57 | 15.88 | 18.05 |
Dr. Lal Path Labs
Dr. Lal Path Labs
1,473.00
-6.30
(-0.43%)
Market Cap
24,680.27 Cr
PE Ratio
45.90
Volume
3,40,879.00
Day High - Low
1,505.00 - 1,446.30
52W High-Low
1,770.00 - 1,146.78
There are new updates from the company1 day ago
View
Key Fundamentals
Market Cap
24,680.27 Cr
EPS
58.48
PE Ratio
45.90
PB Ratio
10.38
Book Value
142.51
EBITDA
789.00
Dividend Yield
0.81 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
22.31
Debt to Equity
0.10
Analyst Rating and Forecast
- By Refinitiv from23 analysts
Actual
Company News
View All News
Dr. Lal PathLabs unveils SOVAAKA, a next-generation diagnostic experience centre in Gurugram, offering personalized wellness programs with advanced diagnostics, AI-supported imaging, and genetic testing.
Dr. Lal PathLabs announces board meeting on January 30, 2026, to approve Q3FY26 unaudited financial results. Trading window closes from January 1 to February 1, 2026.
Dr. Lal PathLabs Limited executed Fifth Supplementary Trust Deed on December 9, 2025, amending Employee Welfare Trust to incorporate new Restricted Stock Unit Plan 2025 under SEBI regulations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,473.00 | #1 24,680.27 | #5 45.90 | #1 2,554.80 | #8 11.28 | #1 492 | #5 16.36 | 51.75 | |
1,029.00 | 10,570.40 | 70.85 | 699.70 | 23.06 | 144 | 2.85 | 57.40 | |
1,989.80 | 10,311.54 | 66.07 | 1,346.30 | 10.64 | 146 | 13.28 | 63.12 | |
464.15 | 7,387.49 | 58.83 | 702.20 | 20.80 | 91 | 81.06 | 56.55 | |
501.05 | 5,027.57 | 73.56 | 769.90 | 33.97 | 67 | - | - | |
753.95 | 2,445.71 | 28.75 | 742.70 | 16.70 | 78 | 22.45 | 52.88 | |
275.05 | 1,432.48 | 45.24 | 255.90 | 15.11 | 31 | -13.73 | 39.65 | |
1,509.80 | 1,295.82 | 25.86 | 111.60 | 28.72 | 48 | 0.67 | 64.84 | |
570.05 | 1,114.02 | #1 25.58 | 147.80 | #1 134.60 | 19 | #1 760.87 | 48.03 | |
324.80 | 1,033.21 | -110.95 | 1,170.80 | -18.47 | -134 | 90.05 | 62.16 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
11.28 %
Net Income Growth
35.88 %
Cash Flow Change
6.27 %
ROE
16.08 %
ROCE
4.10 %
EBITDA Margin (Avg.)
4.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 475 | 625 | 764 | 916 | 1,091 | 1,374 | 1,661 | 2,353 | 2,386 | 2,456 | 2,717 |
| Fixed Assets | 150 | 166 | 190 | 208 | 209 | 413 | 447 | 1,375 | 1,305 | 1,228 | 1,168 |
| Current Assets | 282 | 424 | 511 | 623 | 814 | 893 | 1,145 | 875 | 973 | 1,127 | 1,364 |
| Capital Work in Progress | 1 | 4 | 18 | 10 | 3 | 11 | 10 | 15 | 5 | 6 | 4 |
| Investments | 38 | 64 | 105 | 145 | 185 | 164 | 59 | 66 | 150 | 114 | 327 |
| Other Assets | 286 | 391 | 452 | 554 | 694 | 786 | 1,145 | 898 | 926 | 1,109 | 1,218 |
| Total Liabilities | 475 | 625 | 764 | 916 | 1,091 | 1,374 | 1,661 | 2,353 | 2,386 | 2,456 | 2,717 |
| Current Liabilities | 112 | 91 | 74 | 116 | 138 | 227 | 274 | 500 | 470 | 465 | 402 |
| Non Current Liabilities | 20 | 24 | 28 | 8 | 1 | 93 | 111 | 310 | 216 | 105 | 108 |
| Total Equity | 343 | 510 | 662 | 792 | 951 | 1,054 | 1,276 | 1,544 | 1,700 | 1,885 | 2,207 |
| Reserve & Surplus | 260 | 424 | 577 | 734 | 890 | 974 | 1,162 | 1,425 | 1,583 | 1,766 | 2,089 |
| Share Capital | 81 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 84 | 84 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 8 | -5 | 2 | 37 | 64 | 67 | 48 | 134 | -115 | 97 | -68 |
| Investing Activities | -114 | -164 | -137 | -172 | -100 | -26 | -212 | -449 | -287 | -24 | -303 |
| Operating Activities | 122 | 159 | 171 | 197 | 219 | 284 | 398 | 447 | 456 | 535 | 569 |
| Financing Activities | -1 | 0 | -32 | 13 | -55 | -190 | -139 | 136 | -283 | -414 | -334 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 55.23 % | 55.23 % | 55.23 % | 55.23 % | 55.23 % | 55.05 % | 55.05 % | 55.05 % | 55.03 % | 55.01 % | 54.61 % | 54.60 % | 54.60 % | 54.60 % | 53.92 % | 53.91 % | 53.91 % | 53.79 % | 53.21 % | 53.21 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 2.00 % | 1.83 % | 0.00 % | 0.00 % | 0.00 % | 26.15 % | 25.42 % | 26.82 % | 26.82 % | 23.91 % | 21.68 % | 21.86 % | 20.68 % |
| DIIs | 6.47 % | 5.61 % | 4.84 % | 5.58 % | 5.69 % | 5.30 % | 5.09 % | 6.19 % | 6.55 % | 7.33 % | 7.97 % | 8.61 % | 9.69 % | 12.71 % | 12.89 % | 13.17 % | 16.08 % | 17.91 % | 18.49 % | 18.96 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % |
| Public / Retail | 5.70 % | 6.24 % | 6.93 % | 7.45 % | 9.03 % | 10.44 % | 8.24 % | 9.03 % | 9.50 % | 9.31 % | 8.37 % | 7.26 % | 6.47 % | 4.91 % | 4.10 % | 4.01 % | 4.11 % | 5.23 % | 5.19 % | 5.71 % |
| Others | 32.60 % | 32.92 % | 32.99 % | 31.74 % | 30.05 % | 29.22 % | 31.63 % | 27.73 % | 27.09 % | 28.35 % | 29.05 % | 29.53 % | 3.09 % | 2.35 % | 2.27 % | 2.10 % | 2.00 % | 1.38 % | 1.25 % | 1.43 % |
| No of Share Holders | 68,845 | 94,123 | 1,25,953 | 1,35,068 | 1,71,846 | 1,84,508 | 1,71,602 | 1,79,636 | 1,80,163 | 1,74,444 | 1,60,679 | 1,49,901 | 1,46,741 | 1,31,189 | 1,16,606 | 1,16,236 | 1,15,699 | 1,18,656 | 1,12,703 | 1,14,385 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 3 | 4.5 | 6 | 12 | 20 | 12 | 12 | 24 | 24 | 0.00 |
| Dividend Yield (%) | 0.68 | 0.86 | 0.86 | 0.89 | 1.53 | 1.31 | 1.06 | 1.94 | 1.62 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Jan 2026 |  Quarterly Result Announcement | NA | 30 Jan 2026 | 1,405.45 | 1,479.30 |
| 10 Feb 2021 |  Dividend | ₹ 6.00 /share | 09 Feb 2021 | 1,124.75 | 1,202.23 |
| 22 Jul 2021 | Dividend | ₹ 8.00 /share | 20 Jul 2021 | 1,427.28 | 1,685.48 |
| 22 Aug 2021 | Dividend | ₹ 6.00 /share | 18 Aug 2021 | 1,860.48 | 1,925.18 |
| 23 Jun 2022 | Dividend | ₹ 6.00 /share | 22 Jun 2022 | 1,103.18 | 986.45 |
| 09 Aug 2022 | Dividend | ₹ 6.00 /share | 05 Aug 2022 | 1,085.05 | 1,209.03 |
| 11 Aug 2023 | Dividend | ₹ 6.00 /share | 11 Aug 2023 | 974.93 | 1,182.18 |
| 11 Aug 2023 | Dividend | ₹ 6.00 /share | 11 Aug 2023 | 1,241.75 | 1,182.18 |
| 13 Feb 2024 | Dividend | ₹ 12.00 /share | 13 Feb 2024 | 1,258.70 | 1,229.38 |
| 10 Jun 2024 | Dividend | ₹ 6.00 /share | 10 Jun 2024 | 1,115.78 | 1,398.88 |
| 29 Jun 2024 |  Annual General Meeting | NA | 29 Jun 2024 | 1,115.78 | 1,389.85 |
| 20 Aug 2024 | Dividend | ₹ 6.00 /share | 20 Aug 2024 | 1,584.23 | 1,655.10 |
| 23 Oct 2024 | Quarterly Result Announcement | NA | 23 Oct 2024 | 1,696.15 | 1,654.95 |
| 05 Nov 2024 | Dividend | ₹ 6.00 /share | 05 Nov 2024 | 1,654.95 | 1,534.05 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,421.38 | 1,379.50 |
| 05 Feb 2025 | Dividend | ₹ 6.00 /share | 05 Feb 2025 | 1,379.50 | 1,414.85 |
| 06 Feb 2025 |  Extraordinary General Meeting | NA | 06 Feb 2025 | 1,396.25 | 1,396.25 |
| 25 Apr 2025 | Quarterly Result Announcement | NA | 25 Apr 2025 | 1,357.05 | 1,394.10 |
| 06 Jun 2025 | Dividend | ₹ 6.00 /share | 06 Jun 2025 | 1,394.10 | 1,428.40 |
| 28 Jun 2025 | Annual General Meeting | NA | 28 Jun 2025 | 1,394.10 | 1,385.63 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 1,508.50 | 1,549.55 |
| 06 Aug 2025 | Dividend | ₹ 6.00 /share | 06 Aug 2025 | 1,549.55 | 1,597.20 |
| 31 Oct 2025 | Quarterly Result Announcement | NA | 31 Oct 2025 | 1,535.60 | 1,544.70 |
| 07 Nov 2025 | Dividend | ₹ 7.00 /share | 07 Nov 2025 | 1,544.70 | 1,554.00 |
| 19 Dec 2025 |  Bonus | 1:1 | 19 Dec 2025 | 1,443.78 | 1,396.80 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1 day ago
1 day agoClosure of Trading Window9 days ago
9 days agoBoard Meeting Intimation for Notice Of Board Meeting9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-AllotmentDec 22, 2025
Dec 22, 2025Amended Trust Deed (ESOP)Dec 15, 2025
Dec 15, 2025Intimation Of Record Date For The Purpose Of Issuing Bonus Equity SharesDec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationDec 08, 2025
Dec 08, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 08, 2025
Dec 08, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 26, 2025
Nov 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Nov 08, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 01, 2025
Nov 01, 2025Receipt Of An Assessment Order And Demand Notice Issued By Income Tax DepartmentNov 01, 2025
Nov 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationOct 31, 2025
Oct 31, 2025Record Date For 2Nd Interim Dividend FY 2025-26Oct 31, 2025
Oct 31, 2025Introduction Of Dr. Lal Pathlabs Employee RSU 2025 (ESOP Scheme)Oct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesOct 31, 2025
Oct 31, 2025Corporate Action-Board recommends Bonus IssueOct 31, 2025
Oct 31, 2025Financial Results For The Quarter And Half Year Ended September 30 2025Oct 31, 2025
Oct 31, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On October 31 2025Oct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 27, 2025
Oct 27, 2025Board Meeting Intimation for Notice Of Board MeetingOct 24, 2025
Oct 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Jul 31, 2025Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationJul 31, 2025
Jul 31, 2025Record Date For Interim Dividend FY 2025-26Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 31, 2025
Jul 31, 2025Board Meeting Outcome for Outcome Of Board Meeting - July 31 2025Jul 31, 2025
Jul 31, 2025Results- Financial Results For The Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2025
Jul 24, 2025Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30 2025 And Interim Dividend If AnyJul 24, 2025
Jul 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 28, 2025
Jun 28, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 51.75
ATR(14)
Volatile 41.73
STOCH(9,6)
Overbought 84.88
STOCH RSI(14)
Overbought 80.47
MACD(12,26)
Bullish 13.26
ADX(14)
Weak Trend 22.73
UO(9)
Bearish 64.13
ROC(12)
Uptrend And Accelerating 5.91
WillR(14)
Neutral -23.66
About Dr. Lal Path Labs
Dr Lal PathLabs is a leading diagnostic healthcare service provider in India. The company operates a nationwide network of medical laboratory centers, offering over 5000 diagnostic tests and related healthcare services. Its infrastructure includes a National Reference Laboratory in New Delhi, Regional Reference Labs in Kolkata, Bangalore, and Mumbai, 371...more
Listing Date
23 Dec, 2015(10 Years,
15 days)
Website
Chairperson NameArvind Lal
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
